TECH - Bio-Techne Corp
IEX Last Trade
74.03
-0.490 -0.662%
Share volume: 842,930
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$74.52
-0.49
-0.66%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2022-08-24 | 2022-11-07 | 2023-02-07 | 2023-05-08 | 2023-08-23 | 2023-11-07 | 2024-02-07 | 2024-05-06 | |
| Assets | |||||||||
| Total Assets | 2.295 B | 2.351 B | 2.363 B | 2.600 B | 2.639 B | 2.755 B | 2.731 B | 2.721 B | |
| Current Assets | 605.556 M | 552.031 M | 565.183 M | 570.996 M | 621.482 M | 591.477 M | 590.640 M | 610.650 M | |
| Inventories | 141.123 M | 150.009 M | 160.233 M | 169.464 M | 171.638 M | 186.080 M | 180.839 M | 179.496 M | |
| Other Current Assets | 22.856 M | 24.773 M | 23.431 M | 27.920 M | 27.066 M | 52.164 M | 40.051 M | 31.286 M | |
| Short Term Investments | 22.856 M | 24.773 M | 23.431 M | 27.920 M | 27.066 M | 52.164 M | 40.051 M | 31.286 M | |
| Total Receivables | 194.548 M | 174.174 M | 184.763 M | 216.415 M | 218.468 M | 204.570 M | 207.451 M | 227.887 M | |
| Current Cash | 247.029 M | 203.075 M | 196.756 M | 157.197 M | 204.310 M | 148.663 M | 135.652 M | 145.312 M | |
| Total Non-current Assets | 1.689 B | 1.799 B | 1.798 B | 2.029 B | 2.017 B | 2.164 B | 2.140 B | 2.111 B | |
| Property Plant Equipment | 223.242 M | 224.098 M | 223.851 M | 223.571 M | 226.200 M | 231.683 M | 234.204 M | 243.728 M | |
| Other Assets | 46.828 M | 53.895 M | 53.194 M | 26.354 M | 29.445 M | 29.932 M | 24.629 M | 24.156 M | |
| Intangible Assets | 531.522 M | 585.534 M | 567.647 M | 553.257 M | 534.645 M | 578.971 M | 550.605 M | 526.428 M | |
| Goodwill | 822.101 M | 865.418 M | 869.589 M | 870.542 M | 872.737 M | 969.376 M | 980.082 M | 970.966 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.295 B | 2.351 B | 2.363 B | 2.600 B | 2.639 B | 2.755 B | 2.731 B | 2.721 B | |
| Total liabilities | 593.035 M | 599.567 M | 536.295 M | 710.010 M | 672.176 M | 757.614 M | 767.194 M | 706.795 M | |
| Total current liabilities | 176.018 M | 137.629 M | 128.395 M | 141.163 M | 128.509 M | 127.754 M | 135.231 M | 149.820 M | |
| Accounts Payable | 33.865 M | 30.475 M | 24.100 M | 27.120 M | 25.679 M | 28.084 M | 31.514 M | 28.895 M | |
| Other liabilities | 17.239 M | 19.601 M | 18.336 M | 10.973 M | 10.919 M | 9.394 M | 17.361 M | 11.557 M | |
| Current long term debt | 12.500 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 243.410 M | 264.661 M | 200.000 M | 370.000 M | 350.000 M | 440.000 M | 447.000 M | 389.000 M | |
| Other liabilities | 17.239 M | 19.601 M | 18.336 M | 10.973 M | 10.919 M | 9.394 M | 17.361 M | 11.557 M | |
| Minority interest | -759.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.702 B | 1.751 B | 1.827 B | 1.890 B | 1.967 B | 1.998 B | 1.964 B | 2.014 B | |
| Common stock | 39.200 M | 39.232 M | 157.011 M | 157.311 M | 157.466 M | 158.130 M | 157.533 M | 157.309 M | |
| Retained earnings | 1.123 B | 1.163 B | 1.200 B | 1.247 B | 1.309 B | 1.328 B | 1.261 B | 1.298 B |